XRCC2 and neoplasm: There was no significant correlation between RAD51D or XRCC2 radiomics score and lymphatic vessel invasion, vascular invasion, tumor size, p53 expression level, CerbB2 expression level, or Ki‐67 expression level (Figure S4).